Table 2.
No. of patients (%) | |
---|---|
Sex | |
Male | 10 (91) |
Female | 1 (9) |
Clinical T stage | |
T1 | 3 (27) |
T2 | 3 (27) |
T3b | 3 (27) |
T4a | 1 (9) |
T4b | 1 (9) |
Clinical N stage | |
N0 | 10 (91) |
N+ | 1 (9) |
Histology | |
TCC | 7 (64) |
TCC + other | 4 (36) |
Concomitant CIS | 5 (45) |
LVI | 6 (55) |
Hydronephrosis | 3 (27) |
Neoadjuvant chemotherapy | 9 (82) |
Median no. of nodes examined | 14 |
TCC = transitional cell carcinoma; CIS = carcinoma in situ; LVI = lymphovascular invasion.